Electrochemiluminescence multicomponent immunodetection method based on spectral resolution principle
An immunoassay method and electrochemistry technology, applied in the field of electrochemiluminescence multi-component immunoassay, can solve the problems that ECL analysis technology is still under development, consume a lot of reagents and samples, and take a long time to achieve monochromaticity Good results with less sample consumption and less work
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0075] An electrochemiluminescent multi-component immunoassay method based on the principle of spectral resolution, comprising the following steps:
[0076] (1) Preparation of corresponding secondary antibodies labeled with three kinds of quantum dots
[0077] Add 10 μL phosphate buffer solution containing 100 mg / mL 1-ethyl-3,3-dimethylaminopropylcarbodiimide and 10 μL containing 100mg / mL N-hydroxysuccinimide phosphate buffer solution, react at room temperature for 30min; after centrifugation and purification at 12000rpm, take the precipitate and add 100μL phosphate buffer solution for ultrasonic dispersion, take 15μL of the above-mentioned activated CdSe quantum dot solution and add 150 μL of 100 μg / mL carcinoembryonic antigen secondary antibody, shake at room temperature for 3 hours; then add 20 μL of 1% volume concentration of bovine serum albumin, incubate at room temperature for 1 hour, centrifuge and purify at 12000 rpm, take the precipitate and add 100 μL of phosphate b...
Embodiment 2
[0088] A multi-component immunoassay method based on electrochemiluminescence, the steps are the same as in Example 1, except that:
[0089] Carcinoembryonic antigen, prostate specific antigen, and alpha-fetoprotein antigen were replaced by carbohydrate antigen 125, carbohydrate antigen 15-3, and carbohydrate antigen 72-4, respectively.
Embodiment 3
[0091] A multi-component immunoassay method based on electrochemiluminescence, the steps are the same as in Example 1, except that:
[0092] Carcinoembryonic antigen, prostate specific antigen, and alpha-fetoprotein antigen were replaced by carbohydrate antigen 19-9, free prostate specific antigen, and AIDS antigen, respectively.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com